跳至主要内容
临床试验/NCT01907191
NCT01907191终止不适用

Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.

Trinity Health Of New England1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2013年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
23
试验地点
1
主要终点
Opioid Consumption (Mean Number of 5mg Oxycontin Tablets Consumed)

研究概览

简要总结

This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours

详细描述

Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients having hip arthroscopy

排除标准

  • History of neurologic disease, neuropathy, diabetes
  • Allergy to local anesthetic solution
  • Chronic use of narcotics
  • Inability to give consent/cooperate with study
  • History of previous hip arthroscopy on the ipsilateral side
  • Pregnancy

研究组 & 干预措施

Liposomal bupivacaine

Experimental

Ultrasound guided injection of liposomal bupivacaine for patients undergoing hip arthroscopy

干预措施: liposomal bupivacaine (Drug)

Bupivacaine

Active Comparator

Bupivacaine (around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy

干预措施: Bupivacaine (Drug)

结局指标

主要结局

Opioid Consumption (Mean Number of 5mg Oxycontin Tablets Consumed)

时间窗: Post Operative Day 1, 2 & 3

Consumption of 5mg Oxycontin tablets will be assessed on Post Operative Days 1, 2 \& 3.

次要结局

  • Pain Scores(Post Operative Day 1, 2 & 3)

研究者

发起方
Trinity Health Of New England
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验